Pancreatic Cancer Research

ResearcherKobe UniversityActive in the last 2 years

Sadaki Asari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3969-1104; OpenAlex author ID A5051767609. Sources: OpenAlex.

Their work

Papers
20
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 4 papers

Papers 20

  1. Intraoperative frozen section analysis of the portal or superior mesenteric vein transection margin in pancreatectomy with venous resection for pancreatic canc… Co-author DOI 10.1016/j.gassur.2026.102410↗
  2. Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer. Co-author DOI 10.1245/s10434-025-18491-3↗
  3. ASO Visual Abstract: Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer. Co-author DOI 10.1245/s10434-025-18718-3↗
  4. Delayed Initiation of S-1 Adjuvant Chemotherapy Impairs Survival in Patients With Curatively Resected Pancreatic Cancer. Co-author DOI 10.21873/anticanres.18004↗
  5. Prognostic Significance of GLIM-Defined Malnutrition in Patients With Resectable Pancreatic Adenocarcinoma Following Upfront Surgery. Co-author DOI 10.1002/ags3.70059↗
  6. Preoperative level of serum transthyretin as a novel biomarker predicting survival in resected pancreatic ductal adenocarcinoma with neoadjuvant therapy. Co-author DOI 10.1016/j.pan.2024.07.012↗
  7. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.asjsur.2022.03.043↗
  8. [A Patient with Ascending Jejunal Mesentery Metastasis of Pancreatic Cancer after a Subtotal Stomach-Preserving Pancreaticoduodenectomy]. Co-author PMID 35045476↗
  9. [A Case of Pancreatic Cancer with Gastric Wall Recurrence after Laparoscopic Distal Pancreatectomy Due to Needle Tract Seeding following EUS-FNA]. Co-author PMID 35045477↗
  10. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Ad… Co-author DOI 10.1245/s10434-017-6274-8↗
  11. Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases. Co-author DOI 10.1186/s40792-017-0348-5↗
  12. [A Case of Pancreatic Cancer with Multiple Lymph Node Swelling Caused by Sarcoidosis]. Co-author PMID 29394809↗
  13. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophi… Co-author DOI 10.1007/s00595-015-1206-3↗
  14. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center r… Co-author DOI 10.1016/j.pan.2015.09.008↗
  15. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-014-4280-7↗
  16. [A case of adjuvant surgery for a patient with initially unresectable locally advanced pancreatic cancer (LAPC) with a favorable response to S-1 chemotherapy]. Co-author PMID 25731462↗
  17. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.cgh.2012.12.033↗
  18. [A case of metachronous pancreatic cancer that developed 4 years after initial pancreatectomy]. Co-author PMID 24393957↗
  19. [A case of interstitial lung disease associated with gemcitabine treatment in a patient with locally advanced pancreatic cancer following proton beam radiother… Co-author PMID 23268009↗
  20. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. Co-author DOI 10.1007/s11605-011-1543-5↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takumi Fukumoto · 20 shared papers, 2011–2026 · strength 2.31
  2. Jun Ishida · 13 shared papers, 2013–2026 · strength 1.99
  3. Hirochika Toyama · 14 shared papers, 2011–2026 · strength 1.83
  4. Hiroaki Yanagimoto · 9 shared papers, 2021–2026 · strength 1.82
  5. Takuya Mizumoto · 9 shared papers, 2017–2026 · strength 1.65
  6. Yoshihide Nanno · 9 shared papers, 2014–2026 · strength 1.62
  7. Dongha Lee · 5 shared papers, 2025–2026 · strength 1.27
  8. Sachiyo Shirakawa · 7 shared papers, 2012–2023 · strength 0.49
  9. Ippei Matsumoto · 9 shared papers, 2011–2023 · strength 0.44
  10. Tadahiro Goto · 10 shared papers, 2011–2017 · strength 0.42
  11. Yonson Ku · 10 shared papers, 2011–2017 · strength 0.42
  12. Yuta Ogura · 3 shared papers, 2021–2023 · strength 0.37
  13. Yu Asakura · 2 shared papers, 2021–2023 · strength 0.26
  14. Motofumi Tanaka · 4 shared papers, 2014–2018 · strength 0.23
  15. Keitaro Sofue · 2 shared papers, 2017–2018 · strength 0.13
  16. Takashi Shimizu · 1 shared paper, 2021 · strength 0.11
  17. Masaki Tanaka · 2 shared papers, 2012–2015 · strength 0.07
  18. Mototsugu Shimokawa · 1 shared paper, 2015 · strength 0.04
  19. Yoshiaki Murakami · 1 shared paper, 2015 · strength 0.04
  20. Sohei Satoi · 1 shared paper, 2015 · strength 0.04
  21. Masanao Kurata · 1 shared paper, 2015 · strength 0.04
  22. Masayuki Sho · 1 shared paper, 2015 · strength 0.04
  23. Hiroki Yamaue · 1 shared paper, 2015 · strength 0.04
  24. Kenichiro Uemura · 1 shared paper, 2015 · strength 0.04
  25. Takahiro Akahori · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.